세계의 후버니들 시장

Global Huber Needles Market to Reach US$94.3 Million by 2030

The global market for Huber Needles estimated at US$67.8 Million in the year 2023, is expected to reach US$94.3 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. IV Cancer Treatment Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$45.7 Million by the end of the analysis period. Growth in the Blood Transfusions Application segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.4 Million While China is Forecast to Grow at 4.5% CAGR

The Huber Needles market in the U.S. is estimated at US$18.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$14.8 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Huber Needles Market - Key Trends and Drivers Summarized

Are Huber Needles the Key to Safe and Efficient Long-Term Medication Delivery?

Huber needles have become an indispensable tool in modern healthcare, but why are they so essential for the safe and efficient delivery of medications over extended periods? A Huber needle is a specialized, non-coring needle designed to access implanted vascular access devices, such as ports used in patients requiring long-term intravenous (IV) treatments. These needles are widely used in patients undergoing chemotherapy, blood transfusions, or long-term IV therapy, as they provide a reliable and safe way to administer medication without repeatedly puncturing veins.

The appeal of Huber needles lies in their unique design, which minimizes tissue damage and reduces the risk of coring (where a small piece of tissue is cut and introduced into the bloodstream). This makes them ideal for patients who need frequent or long-term access to central venous ports. Huber needles offer both comfort and safety, ensuring that treatments are delivered effectively without causing unnecessary pain or complications. As healthcare providers seek to enhance patient care in chronic treatment settings, Huber needles are critical for maintaining the integrity of vascular access devices while minimizing discomfort and risk.

How Has Technology Advanced Huber Needles?

Technological advancements have significantly improved the safety, functionality, and ease of use of Huber needles, making them more efficient and reliable for long-term medication delivery. One of the most important developments is the introduction of safety-engineered Huber needles. These needles are equipped with safety mechanisms that protect healthcare workers from accidental needlestick injuries, which can expose them to bloodborne pathogens. Safety features like automatic needle retraction or shielding have become standard in many Huber needles, reducing the risk of injury and promoting a safer work environment in clinical settings.

Improved materials and coatings have also enhanced the performance of Huber needles. Modern Huber needles are often made with advanced stainless steel, which provides durability, flexibility, and biocompatibility. Some needles feature coatings that reduce friction during insertion, making the process smoother and more comfortable for patients. These coatings can also help minimize trauma to the surrounding tissue, reducing irritation and the potential for infection around the port site.

In addition to safety and material improvements, the design of Huber needles has become more refined, with innovations that enhance precision and patient comfort. Many newer models have angled or ergonomic designs that make them easier for healthcare providers to handle and position accurately. This leads to fewer complications during insertion and more consistent access to the patient’s port. Additionally, the ergonomic design improves the overall user experience for nurses and doctors, who must often handle these needles in complex, high-pressure environments.

Flow-controlled Huber needles represent another significant advancement. These needles are designed to improve the flow of medication or fluids through the needle, ensuring that dosages are administered more efficiently. In the context of chemotherapy or blood transfusions, ensuring accurate and steady flow rates is crucial for both the efficacy of treatment and patient safety. Flow-controlled Huber needles help reduce the likelihood of blockages or inconsistent delivery, which can compromise patient care.

The availability of smaller gauge Huber needles has also expanded the applications of these devices. Smaller gauge needles cause less pain and tissue damage upon insertion, making them more comfortable for patients, especially those requiring frequent treatments. These finer needles are particularly beneficial for pediatric patients or individuals with more sensitive skin or tissue, as they minimize discomfort while maintaining effective port access.

Why Are Huber Needles Critical for Long-Term Patient Care and Medication Delivery?

Huber needles are critical for long-term patient care and medication delivery because they provide a safe, reliable, and less invasive method for accessing vascular ports in patients who require frequent IV treatments. Many patients undergoing chemotherapy, chronic pain management, or long-term IV therapy benefit from implanted ports, which allow healthcare providers to administer treatments directly into the bloodstream. Huber needles are specially designed to access these ports without damaging them, ensuring that the port remains functional over extended periods.

One of the primary advantages of Huber needles is their non-coring design. When a Huber needle punctures a vascular port, it does not remove tissue, thereby reducing the risk of coring and contamination of the bloodstream. This feature is essential for maintaining the integrity of the port and preventing complications such as infections or blockages. For patients who depend on their ports for life-saving treatments, ensuring the longevity and safety of the port is crucial, and Huber needles play a vital role in this process.

Huber needles also improve patient comfort by reducing the pain and trauma associated with repeated needle insertions. Traditional needles can cause significant discomfort and tissue damage when used to access a port multiple times. However, the design of Huber needles minimizes tissue trauma, making them a preferred option for long-term treatment regimens. This is especially important in chemotherapy patients, who may need weekly or even daily access to their ports over the course of several months or years. The use of Huber needles helps minimize pain, reduces the risk of infection, and promotes better overall patient well-being.

The safe and controlled delivery of medications is another reason why Huber needles are so important. In treatments such as chemotherapy, where precise dosing and timing are essential, Huber needles ensure that the medication is delivered directly into the bloodstream without complications. Their reliability is critical in reducing the risk of drug leaks, blockages, or other issues that could compromise the efficacy of treatment. Additionally, their compatibility with a wide range of IV therapies and infusion rates makes them versatile for various clinical applications, from chemotherapy to parenteral nutrition.

Huber needles are also vital for the protection of healthcare workers. With the integration of safety-engineered features, Huber needles help prevent accidental needlestick injuries, which can transmit bloodborne diseases such as HIV or hepatitis. In busy clinical environments where healthcare workers may handle multiple needles daily, the safety features of Huber needles provide an added layer of protection, ensuring that treatments are administered without putting staff at risk.

What Factors Are Driving the Growth of the Huber Needles Market?

Several factors are driving the growth of the Huber needles market, including the rising prevalence of chronic diseases, increasing demand for chemotherapy and other long-term treatments, and advancements in needle safety technology. One of the primary drivers is the growing number of patients requiring long-term intravenous therapies, particularly those undergoing cancer treatment. As the global incidence of cancer rises, more patients are being treated with chemotherapy, often through vascular access devices like ports. The need for safe and reliable access to these devices is contributing to the increased demand for Huber needles, which offer a non-coring, comfortable, and effective solution for port access.

The expanding use of implanted ports for a variety of chronic conditions is another key factor fueling market growth. Ports are not only used in oncology but also in patients with autoimmune diseases, chronic pain conditions, or those needing long-term nutrition support via parenteral nutrition. As these treatments become more common, the demand for Huber needles that can safely access these ports without causing complications will continue to grow.

Advancements in needle safety technology are also driving market expansion. With increased awareness of needlestick injuries and the associated health risks, there is a growing emphasis on the development and adoption of safety-engineered Huber needles. These needles reduce the risk of accidental exposure to bloodborne pathogens, protecting both healthcare workers and patients. The focus on improving occupational safety in healthcare settings has led to wider adoption of safety needles, contributing to the overall growth of the Huber needles market.

The aging population is another significant driver of market growth. As the global population ages, the number of individuals living with chronic diseases such as cancer, cardiovascular conditions, and diabetes is increasing. Many of these patients require long-term IV therapies or regular access to vascular ports, driving the demand for Huber needles. Additionally, elderly patients may have more delicate veins, making Huber needles a preferred option for minimizing tissue damage and ensuring comfort during treatments.

Technological advancements in the design and materials used in Huber needles have also contributed to market growth. Innovations that enhance the precision, comfort, and safety of Huber needles have made them more attractive to healthcare providers. The development of smaller gauge needles, more ergonomic designs, and advanced safety features has improved the user experience for both patients and healthcare workers. As these innovations continue, the market for Huber needles is expected to expand further, with healthcare providers seeking the best tools to deliver long-term, high-quality care.

The increasing focus on patient-centered care is another factor influencing the growth of the Huber needles market. As healthcare providers place greater emphasis on improving the quality of life for patients undergoing long-term treatments, there is a growing demand for medical devices that minimize discomfort and complications. Huber needles, with their design focused on reducing pain and protecting vascular ports, align with these goals, making them a critical component in patient care strategies.

With the rising prevalence of chronic diseases, advancements in safety technology, and the growing need for long-term treatment solutions, the Huber needles market is poised for continued growth. As healthcare providers prioritize safety, efficiency, and patient comfort, Huber needles will remain an essential tool in ensuring the safe and effective delivery of critical therapies across various medical disciplines.

Select Competitors (Total 41 Featured) -

• AngioDynamics, Inc.
• B. Braun Medical, Inc.
• BARD, A Becton, Dickinson Company
• Baxter International, Inc.
• EXELINT International Co.
• Nipro Medical Corporation
• Smiths Medical
• Thibaut SAS
• Vygon SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Huber Needles - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Oncology and Chronic Disease Management Drives Growth in Huber Needles Market
  • Expansion of Intravenous Drug Administration and Parenteral Nutrition Spurs Adoption of Huber Needles
  • Growth in Use of Huber Needles for Long-term Vascular Access Expands Addressable Market
  • Role of Huber Needles in Enhancing Patient Comfort and Reducing Needle-stick Injuries Strengthens Business Case for Adoption
  • Growth in Use of Huber Needles in Chemotherapy and Blood Transfusions Expands Market Opportunities
  • Role of Huber Needles in Supporting Home-based Infusion Therapy and Parenteral Nutrition Expands Addressable Market
  • Growth in Use of Huber Needles in Central Venous Catheterization and Port Access Strengthens Market Demand
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Huber Needles Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for IV Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Blood Transfusions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Lap-Band Adjustments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Home Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Curved Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Straight by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• JAPAN
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• CHINA
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 47: China Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 49: China 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 52: China 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• EUROPE
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• FRANCE
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 64: France 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 65: France Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 67: France 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• GERMANY
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 83: UK Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of World Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of World 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Rest of World Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 103: Rest of World 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030

IV. COMPETITION